Print page Close print preview
Logo Going International

Neurodevelopmental Drug Development Summit

Evvnt Promotion / evvnt
14.12.2021 - 15.12.2021  Online
Time: 8:30 am - 6:15 pm
Temas de la conferencia
As investment in rare neurodevelopmental disorders is surging, there has never been a better time to unite all the key stakeholders across this fast-evolving community.

The inaugural Neurodevelopmental Drug Development Summit is the definitive industry-dedicated forum for large pharma, biotech, academia, and patient advocacy groups paving the way towards symptomatic and successful disease modifying treatments.
Organizador profesional (PCO)
Hanson Wade

Speakers: Allyson Berent Chief Operating Officer | FAST GeneTx | Biotherapeutics Chief Scientific Officer, Anish Bhatnagar Chief Executive Officer Soleno Therapeutics and more

Información e inscripción:
Ms. Stephanie Nketia
Medicina General
Cuota del Congreso
Conference Only - Drug Developer: USD 2099.00, Conference Only - Academic: USD 1899.00, Conference Only - Service Provider: USD 2599.00
Los participantes esperaban
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom